Patents by Inventor Irina Alkhairi

Irina Alkhairi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MicroRNA ANGPTL3 inhibitor
    Patent number: 11058710
    Abstract: The microRNA ANGPTL3 inhibitor includes methods of administering a miRNA capable of inhibiting ANGTPL3 and/or dyslipidemia to a subject in need thereof. The methods of administering the miRNA ANGPTL3 inhibitor may include administration of miRNA-181d to a subject in need thereof. The administration of miRNA-181d may inhibit ANGPTL3 activity, thereby reducing ANGPTL3's inhibition of lipoprotein lipase activity and increasing triglyceride degradation. The administration of miRNA-181d may be used to treat or prevent lipid metabolism disorders including dyslipidemia and dyslipidemia associated diseases, such as hyperlipidemia, atherosclerosis, heart disease, and the like.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: July 13, 2021
    Assignee: DASMAN DIABETES INSTITUTE
    Inventors: Jehad Abubaker, Mohamed Abufarha, Fahd Al Mulla, Irina Alkhairi, Preethi Cherian
  • Microrna dyslipidemia inhibitor
    Patent number: 10844383
    Abstract: The microRNA dyslipidemia inhibitor includes methods of administering a miRNA capable of inhibiting dyslipidemia to a subject in need thereof. The methods of the miRNA dyslipidemia inhibitor may include administration of miRNA-103 to a subject in need thereof. The administration of miRNA-103 may inhibit ANGPTL8 activity, thereby reducing ANGPTL8's inhibition of lipoprotein lipase activity and increasing triglyceride degradation. The administration of miRNA-103 may be used to treat or prevent lipid metabolism disorders including dyslipidemia and dyslipidemia associated diseases, such as hyperlipidemia, atherosclerosis, heart disease, and the like.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: November 24, 2020
    Assignee: DASMAN DIABETES INSTITUTE
    Inventors: Mohamed Abufarha, Jehad Abubaker, Fahd Al Mulla, Preethi Cherian, Irina Alkhairi